FluoroType MTBDR第2版检测结核分枝杆菌复合群及耐药突变的双中心评估:来自丹麦、德国和塞拉利昂的肺部与肺外样本
该双中心评估用FluoroType MTBDR第2版(FTv2)实时PCR检测肺部和肺外样本中的结核分枝杆菌复合群(MTBC)DNA及利福平(RIF)和异烟肼(INH)耐药突变,并与培养和复合参考DNA比较。FTv2在丹麦和德国痰标本中敏感度分别为0.86和0.90,特异度分别为0.98和1.00;对RIF和INH耐药突变检测敏感度分别为0.99和1.00。
要点
- FTv2检测MTBC DNA在痰标本中敏感度丹麦0.86、德国0.90,特异度0.98和1.00。
- 肺外样本敏感度较低:丹麦0.33、德国0.50,特异度分别为0.99和1.00。
- 与复合参考DNA相比,RIF耐药突变检测敏感度0.99、特异度0.96;INH为1.00和0.98。
核心结论
- FTv2可可靠检测肺部和肺外样本中的MTBC DNA,并能检测inhA启动子、katG和rpoB基因中INH和RIF耐药突变。
研究设计与样本
- 在丹麦1815份和德国432份样本中评估FTv2检测MTBC;在德国样本及塞拉利昂110份样本中评估RIF和INH耐药突变,并与表型药敏试验及基于GenoType MTBDR线探针 assay和Sanger测序或全基因组测序的复合参考DNA(CRD)比较。
主要发现
- 丹麦584份痰标本(557份涂片阴性)中42份(16份涂片阴性)培养阳性,44份(18份涂片阴性)FTv2阳性;德国277份痰标本(85份涂片阴性)中246份(54份涂片阴性)培养阳性,222份(35份涂片阴性)FTv2阳性。
- 丹麦痰标本FTv2敏感度0.86(涂片阴性0.63)、特异度0.98;德国痰标本敏感度0.90(涂片阴性0.65)、特异度1.00。
- 全部肺部样本:丹麦1434份,敏感度0.79、特异度0.99;德国347份,敏感度0.86、特异度1.00。
- 肺外样本:丹麦381份,敏感度0.33、特异度0.99;德国83份,敏感度0.50、特异度1.00。
- 与CRD相比检测耐药突变:RIF有效例数355,敏感度0.99、特异度0.96;INH有效例数340,敏感度1.00、特异度0.98。
关键数值与推荐
- RIF耐药突变检测(vs CRD):有效例数355,敏感度0.99,特异度0.96。
- INH耐药突变检测(vs CRD):有效例数340,敏感度1.00,特异度0.98。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We evaluated the ability of FluoroType MTBDR version 2 (FTv2; Hain Lifescience), a second-step real-time PCR assay, to simultaneously detect Mycobacterium tuberculosis complex (MTBC) DNA and mutations conferring resistance to rifampicin (RIF) and isoniazid (INH), in pulmonary and extrapulmonary samples from patients and compared them with corresponding cultures. METHODS: FTv2 MTBC was evaluated on 1815 and 432 samples from Denmark (DK) and Germany (DE), respectively. RIF and INH resistance mutations were assessed in the German samples and 110 samples from Sierra Leone and subsequently compared to phenotypic antimicrobial susceptibility testing and a composite reference DNA (CRD) based on the GenoType MTBDR line-probe assay and Sanger sequencing or whole-genome sequencing. RESULTS: Of the 584 (557 smear-negative) Danish and 277 (85 smear-negative) German sputum samples, 42 (16) and 246 (54) were culture positive, and 44 (18) and 222 (35) were FTv2 positive, providing an FTv2 sensitivity and specificity of 0.86 (0.63) and 0.98 (DK), 0.90 (0.65) and 1.00 (DE), respectively. The count, sensitivities, and specificities for all pulmonary samples were 1434, 0.79, and 0.99 (DK) and 347, 0.86, and 1.00 (DE), respectively; for extrapulmonary samples, 381, 0.33, 0.99 (DK) and 83, 0.50, and 1.00 (DE). The valid count, sensitivity, and specificity compared with CRD for detecting resistance mutations were RIF 355, 0.99, 0.96, and INH 340, 1.00, and 0.98, respectively. DISCUSSION: FTv2 reliably detects MTBC DNA in pulmonary and extrapulmonary samples and detects resistance mutations for INH and RIF resistance in inhA promoter, katG, and rpoB genes.
引用
- Svensson E, Ketelsen H, Andres S, et al. Dual-centre evaluation of the FluoroType MTBDR version 2 assay for detection of Mycobacterium tuberculosis complex and resistance-conferring mutations in pulmonary and extrapulmonary samples from Denmark, Germany and Sierra Leone. Clin Microbiol Infect. 2024. PMID: 38621623. doi:10.1016/j.cmi.2024.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。